Paul Legendre

1.5k total citations
29 papers, 314 citations indexed

About

Paul Legendre is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Paul Legendre has authored 29 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 8 papers in Pathology and Forensic Medicine and 8 papers in Epidemiology. Recurrent topics in Paul Legendre's work include Systemic Sclerosis and Related Diseases (8 papers), Vasculitis and related conditions (5 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Paul Legendre is often cited by papers focused on Systemic Sclerosis and Related Diseases (8 papers), Vasculitis and related conditions (5 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Paul Legendre collaborates with scholars based in France, Italy and Portugal. Paul Legendre's co-authors include Luc Mouthon, Alexis Régent, Benjamin Terrier, Marco Matucci‐Cerinic, Jelena Blagojević, Y. Imbert, J Beylot, Julien Haroche, M. Dupon and D. Neau and has published in prestigious journals such as CHEST Journal, Lara D. Veeken and Autoimmunity Reviews.

In The Last Decade

Paul Legendre

24 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Legendre France 10 100 86 68 67 66 29 314
Sung Hae Chang South Korea 12 86 0.9× 58 0.7× 129 1.9× 77 1.1× 98 1.5× 42 350
Masaru Togashi Japan 11 105 1.1× 57 0.7× 89 1.3× 36 0.5× 39 0.6× 30 296
S. Toquet France 9 44 0.4× 99 1.2× 149 2.2× 88 1.3× 71 1.1× 16 315
S. Miranda France 12 72 0.7× 28 0.3× 131 1.9× 29 0.4× 31 0.5× 32 379
Mizuho Nara Japan 10 103 1.0× 60 0.7× 80 1.2× 22 0.3× 21 0.3× 26 247
Marion Mehrenberger France 11 67 0.7× 110 1.3× 73 1.1× 126 1.9× 205 3.1× 17 451
Hervé Lobbes France 9 71 0.7× 30 0.3× 52 0.8× 35 0.5× 27 0.4× 25 358
M. Le Besnerais France 11 53 0.5× 20 0.2× 89 1.3× 48 0.7× 32 0.5× 23 290
Haoting Zhan China 9 37 0.4× 52 0.6× 59 0.9× 33 0.5× 24 0.4× 38 300
Jennifer Hannah United Kingdom 6 60 0.6× 58 0.7× 138 2.0× 63 0.9× 53 0.8× 18 292

Countries citing papers authored by Paul Legendre

Since Specialization
Citations

This map shows the geographic impact of Paul Legendre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Legendre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Legendre more than expected).

Fields of papers citing papers by Paul Legendre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Legendre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Legendre. The network helps show where Paul Legendre may publish in the future.

Co-authorship network of co-authors of Paul Legendre

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Legendre. A scholar is included among the top collaborators of Paul Legendre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Legendre. Paul Legendre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Legendre, Paul, Barbara Burroni, Tali‐Anne Szwebel, et al.. (2023). EBV-Positive Inflammatory Follicular Dendritic Cell Sarcoma of the Spleen: Report of an Aggressive Form With Molecular Characterization. International Journal of Surgical Pathology. 32(1). 150–154. 3 indexed citations
2.
Legendre, Paul, Sophie Chauvet, Alexandre Karras, et al.. (2023). Digital Ischemia as a Rare Manifestation of C3 Glomerulopathy Associated With Monoclonal Gammopathy. Kidney International Reports. 9(3). 712–716. 1 indexed citations
3.
Asli, Bouchra, Marie‐Thérèse Daniel, Stéphanie Mathis, et al.. (2022). Erythroblastic synartesis associated with lymphoproliferative disorder: There can be more than meets the eye. Clinical Immunology. 236. 108951–108951.
4.
Chaigne, Benjamin, Bertrand Dunogué, Alexis Régent, et al.. (2022). Autoantibodies versus Skin Fibrosis Extent in Systemic Sclerosis: A Case-Control Study of Inverted Phenotypes. Diagnostics. 12(5). 1067–1067. 12 indexed citations
5.
Uzunhan, Y., Romain Paule, Jérémie Dion, et al.. (2021). Presentation, Diagnosis, and Management of Subglottic and Tracheal Stenosis During Systemic Inflammatory Diseases. CHEST Journal. 161(1). 257–265. 14 indexed citations
6.
Régent, Alexis, Benjamin Terrier, Paul Legendre, et al.. (2021). Efficacy of baricitinib for refractory large-vessel vasculitis. Lara D. Veeken. 60(11). e389–e391. 7 indexed citations
7.
Chouchana, Laurent, Inès Gana, Lucile Regard, et al.. (2020). Plasma Concentrations and Safety of Lopinavir/Ritonavir in COVID-19 Patients. Therapeutic Drug Monitoring. 43(1). 131–135. 9 indexed citations
8.
Legendre, Paul, Zora Marjanovic, Marguerite Vignon, et al.. (2020). Utilization of intravenous or subcutaneous immunoglobulins in secondary immune deficiency (ULTIMATE): A retrospective multicenter study. Clinical Immunology. 215. 108419–108419. 16 indexed citations
9.
Uzunhan, Y., Romain Paule, Jacinthe Dion, et al.. (2020). Spectre étiologique des sténoses sous-glottiques dans les maladies dysimmunitaires. La Revue de Médecine Interne. 41. A15–A16.
10.
Dunogué, Bertrand, et al.. (2020). High D-dimer plasma concentration in systemic sclerosis patients: Prevalence and association with vascular complications. Journal of Scleroderma and Related Disorders. 6(2). 178–186. 6 indexed citations
11.
Legendre, Paul, et al.. (2020). P7 Rivaroxaban may trigger catastrophic antiphospholipid syndrome. Poster presentations. A32.1–A32.
12.
Legendre, Paul, Benoı̂t Blanchet, Raphaël Porcher, et al.. (2020). Mycophenolic acid drug monitoring in patients with systemic sclerosis associated with diffuse skin and/or pulmonary involvement: A monocentric and retrospective French study. Journal of Scleroderma and Related Disorders. 6(1). 87–95. 2 indexed citations
13.
Terrier, Benjamin, S. Humbert, Jérôme Razanamahery, et al.. (2020). Risk of scleroderma according to the type of immune checkpoint inhibitors. Autoimmunity Reviews. 19(8). 102596–102596. 45 indexed citations
14.
Chazal, Thibaud, Myrto Costopoulos, Élisabeth Maillart, et al.. (2019). The cerebrospinal fluid CD4/CD8 ratio and interleukin‐6 and ‐10 levels in neurosarcoidosis: a multicenter, pragmatic, comparative study. European Journal of Neurology. 26(10). 1274–1280. 39 indexed citations
15.
Blagojević, Jelena, Paul Legendre, Marco Matucci‐Cerinic, & Luc Mouthon. (2019). Is there today a place for corticosteroids in the treatment of scleroderma?. Autoimmunity Reviews. 18(12). 102403–102403. 19 indexed citations
16.
Legendre, Paul, F. Le Pelletier, Makoto Miyara, et al.. (2018). Glomeruloid haemangioma: a possible consequence of elevated VEGF in POEMS and Erdheim-Chester disease. European Journal of Dermatology. 28(6). 784–789. 2 indexed citations
17.
Legendre, Paul, et al.. (2016). Anti-endothelial cell antibodies in vasculitis: A systematic review. Autoimmunity Reviews. 16(2). 146–153. 42 indexed citations
18.
Legendre, Paul, V. Lalande, Catherine Eckert, et al.. (2015). Clostridium difficile associated reactive arthritis: Case report and literature review. Anaerobe. 38. 76–80. 15 indexed citations
19.
Legendre, Paul & Luc Mouthon. (2014). Hypertension artérielle pulmonaire des connectivites. La Presse Médicale. 43(9). 957–969. 5 indexed citations
20.
Bonnet, Fabrice, Philippe Morlat, D. Neau, et al.. (2000). Manifestations hématologiques et immunologiques de la primo-infection à cytomégalovirus chez l'adulte hospitalisé non immunodéprimé. La Revue de Médecine Interne. 21(7). 586–594. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sung Hae Chang Breakdown of academic impact, for papers by Masaru Togashi Breakdown of academic impact, for papers by S. Toquet Breakdown of academic impact, for papers by S. Miranda Breakdown of academic impact, for papers by Mizuho Nara Breakdown of academic impact, for papers by Marion Mehrenberger Breakdown of academic impact, for papers by Hervé Lobbes Breakdown of academic impact, for papers by M. Le Besnerais Breakdown of academic impact, for papers by Haoting Zhan Breakdown of academic impact, for papers by Jennifer Hannah
Rankless by CCL
2026